Title: Discovery of N-((4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1H-imidazol-2-yl)methyl)-2-fluoroaniline (EW-7197): a highly potent, selective, and orally bioavailable inhibitor of TGF-β type I receptor kinase as cancer immunotherapeutic/antifibrotic agent.
Journal: Journal of medicinal chemistry20140522
Title: A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.
Journal: The Biochemical journal20130415
Title: NODAL and SHH dose-dependent double inhibition promotes an HPE-like phenotype in chick embryos.
Journal: Disease models & mechanisms20130301
Title: Endothelial cell transforming growth factor-β receptor activation causes tacrolimus-induced renal arteriolar hyalinosis.
Journal: Kidney international20121001
Title: Cdk4/6 inhibition induces epithelial-mesenchymal transition and enhances invasiveness in pancreatic cancer cells.
Journal: Molecular cancer therapeutics20121001
Title: Yin-Yang1 is required for epithelial-to-mesenchymal transition and regulation of Nodal signaling during mammalian gastrulation.
Journal: Developmental biology20120815
Title: Transforming growth factor-β2 induces synthesis and secretion of endothelin-1 in human trabecular meshwork cells.
Journal: Investigative ophthalmology & visual science20120807
Title: Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity.
Journal: Nature biotechnology20111101
Title: Synthesis and biological evaluation of 1-substituted-3(5)-(6-methylpyridin-2-yl)-4-(quinoxalin-6-yl)pyrazoles as transforming growth factor-β type 1 receptor kinase inhibitors.
Journal: European journal of medicinal chemistry20110901
Title: Synthesis and biological evaluation of 1-substituted-3(5)-(6-methylpyridin-2-yl)-4-(quinolin-6-yl)pyrazoles as transforming growth factor-β type 1 receptor kinase inhibitors.
Journal: Bioorganic & medicinal chemistry20110415
Title: Smad signaling determines chondrogenic differentiation of bone-marrow-derived mesenchymal stem cells: inhibition of Smad1/5/8P prevents terminal differentiation and calcification.
Journal: Tissue engineering. Part A20110401
Title: Synthesis and biological evaluation of 2-pyridyl-substituted pyrazoles and imidazoles as transforming growth factor-beta type 1 receptor kinase inhibitors.
Journal: Bioorganic & medicinal chemistry letters20100715
Title: Synthesis and biological evaluation of 4(5)-(6-methylpyridin-2-yl)imidazoles and -pyrazoles as transforming growth factor-beta type 1 receptor kinase inhibitors.
Journal: Bioorganic & medicinal chemistry20100615
Title: Hydrogen sulfide attenuates epithelial-mesenchymal transition of human alveolar epithelial cells.
Journal: Pharmacological research20100401
Title: Suppression of transforming growth factor-β effects in rabbit subconjunctival fibroblasts by activin receptor-like kinase 5 inhibitor.
Journal: Molecular vision20100101
Title: Synthesis and biological evaluation of 1,2,4-trisubstituted imidazoles and 1,3,5-trisubstituted pyrazoles as inhibitors of transforming growth factor beta type 1 receptor (ALK5).
Journal: Bioorganic & medicinal chemistry letters20090815
Title: TGF-beta1 induced MMP-9 expression in HNSCC cell lines via Smad/MLCK pathway.
Journal: Biochemical and biophysical research communications20080711
Title: The essential role of fibroblasts in esophageal squamous cell carcinoma-induced angiogenesis.
Journal: Gastroenterology20080601
Title: TGF-beta signaling promotes survival and repair in rat alveolar epithelial type 2 cells during recovery after hyperoxic injury.
Journal: American journal of physiology. Lung cellular and molecular physiology20080401
Title: Synthesis and biological evaluation of 5-(pyridin-2-yl)thiazoles as transforming growth factor-beta type1 receptor kinase inhibitors.
Journal: Bioorganic & medicinal chemistry letters20080315
Title: The role of maternal Activin-like signals in zebrafish embryos.
Journal: Developmental biology20070915
Title: Synthesis and biological evaluation of 4(5)-(6-alkylpyridin-2-yl)imidazoles as transforming growth factor-beta type 1 receptor kinase inhibitors.
Journal: Journal of medicinal chemistry20070628
Title: Time-dependent patterning of the mesoderm and endoderm by Nodal signals in zebrafish.
Journal: BMC developmental biology20070101
Title: SB-505124 is a selective inhibitor of transforming growth factor-beta type I receptors ALK4, ALK5, and ALK7.
Journal: Molecular pharmacology20040301
Title: DaCosta Byfield S, et al. SB-505124 is a selective inhibitor of transforming growth factor-beta type I receptors ALK4, ALK5, and ALK7. Mol Pharmacol. 2004 Mar;65(3):744-52.
Title: Sutariya V, et al. Thermoreversible gel for delivery of receptor-like kinase 5 inhibitor SB-505124 for glaucoma filtration surgery. Pharm Dev Technol. 2013 Jul-Aug;18(4):957-62.
Title: Sapitro J, et al. Suppression of transforming growth factor-β effects in rabbit subconjunctival fibroblasts by receptor-like kinase 5 inhibitor. Mol Vis. 2010 Sep 16;16:1880-92.
Title: Marini KD, et al. Inhibition of activin signaling in lung adenocarcinoma increases the therapeutic index of platinum chemotherapy. Sci Transl Med. 2018 Jul 25;10(451). pii: eaat3504.
